PAPER Forouzannezhad P, Abbaspour A, Li C, Fang C, Williams U, Cabrerizo M, Barreto A, Andrian J, Rishe N, Curiel RE, Loewenstein D, Duara R, Adjouadi M
SEARCH RESULTS
18777 RESULTS
PAPER Lin FY, Lin YF, Lin YS, Yang CM, Wang CC, Hsiao YH
Relative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2.
Neuropharmacology. 2020 Mar 1;164:107910. Epub 2019 Dec 12 PubMed: 31838171PAPER Li A, Zhao J, Fan C, Zhu L, Huang C, Li Q, Gan D, Wen C, Chen M, Lu D
Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease.
Neurobiol Aging. 2020 Feb;86:81-91. Epub 2019 Dec 11 PubMed: 31837910PAPER Samaridou E, Walgrave H, Salta E, Álvarez DM, Castro-López V, Loza M, Alonso MJ
Nose-to-brain delivery of enveloped RNA- cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases.
Biomaterials. 2020 Feb;230:119657. Epub 2019 Dec 6 PubMed: 31837821PAPER Coppola C, Oliva M, Saracino D, Pappatà S, Zampella E, Cimini S, Ricci M, Giaccone G, Di Iorio G, Rossi G
One novel GRN null mutation, two different aphasia phenotypes.
Neurobiol Aging. 2020 Mar;87:141.e9-141.e14. Epub 2019 Nov 12 PubMed: 31837909Deann Dickinson
Spokane, United States
Genomics of Brain Disorders (Virtual Meeting)
CONFERENCE 2021-04-14 00:00:00-2021-04-16 00:00:00 Hinxton, England 14 April 2021 to 16 April 2021 View Conference Website 1
Lauren Massimo
University of Pennsylvania
Jon Turner
PAPER Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux LJ, Van Noord M, Mager U, Strobelberger M, Gaynes BN, Thieda P, Lloyd S, Reichenpfader U, Lohr KN
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review [Internet].
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec. Report No.: 12-EHC012-EF. AHRQ Comparative Effectiveness Reviews.Jürgen Götz on Does a Breached Blood-Brain Barrier Cause Seizures in AD?
COMMENT We would like to contribute to the discussion about blood-borne factors entering the brain, with the two STM studies reporting that age-related impairments in the BBB allow for an influx of albumin into the brain, activating TGFβ receptors, overexciting n
Malu G. Tansey on A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1.
COMMENT The RIP kinase family evolved as part of a host antiviral response. Specifically, programmed necrosis, aka necroptosis, regulated by RIP kinases, represents a host adaptation to mitigate the effects of Caspase-8-targeted cell death suppressors (as shown i
PAPER Kaiser WJ, Upton JW, Mocarski ES
Viral modulation of programmed necrosis.
Curr Opin Virol. 2013 Jun;3(3):296-306. Epub 2013 Jun 15 PubMed: 23773332PAPER Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, Sehon CA, Marquis RW, Bertin J, Mocarski ES
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL.
J Biol Chem. 2013 Oct 25;288(43):31268-79. Epub 2013 Sep 9 PubMed: 24019532PAPER Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, Pan H, Bai R, Zhang J, Wang Y, Lee PY, Ying W, Zhou Q, Hou J, Wang W, Sun B, Yang M, Liu D, Fang R, Han H, Yang Z, Huang X, Li H, Deuitch N, Zhang Y, Dissanayake D, Haude K, McWalter K, Roadhouse C, MacKenzie JJ, Laxer RM, Aksentijevich I, Yu X, Wang X, Yuan J, Zhou Q
A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1.
Nature. 2019 Dec 11; PubMed: 31827280Current Filters
- Date Range : Oct 2019 to Oct 2020 x